The proteasome inhibitor lactacystin enhances GSH synthesis capacity by increased expression of antioxidant components in an Nrf2-independent, but p38 MAPK-dependent manner in rat colorectal carcinoma cells

References

• Adams J. The development of proteasome inhibitors as anticancer drugs. Cancer Cell 2004;5:417–421.
   PubMed Web of Science ®Google Scholar
• Kornitzer D, Ciechanover A. Modes of regulation of ubiquitin-mediated protein degradation. J Cell Physiol 2000;182:1–11.
   PubMed Web of Science ®Google Scholar
• Driscoll JJ, Woodle ES. Targeting the ubiquitin + proteasome system in solid tumors. Semin Hematol 2012;49:277–283.
   PubMed Web of Science ®Google Scholar
• Pal A, Young MA, Donato NJ. Emerging potential of therapeutic targeting of ubiquitin-specific proteases in the treatment of cancer. Cancer Res 2014;74:4955–4966.
   PubMed Web of Science ®Google Scholar
• Bardag-Gorce F, Oliva J, Lin A, Li J, French BA, French SW. Proteasome inhibitor up regulates liver antioxidative enzymes in rat model of alcoholic liver disease. Exp Mol Pathol 2011;90:123–130.
   PubMed Web of Science ®Google Scholar
• Dreger H, Westphal K, Weller A, Baumann G, Stangl V, Meiners S, Stangl K. Nrf2-dependent upregulation of antioxidative enzymes: a novel pathway for proteasome inhibitor-mediated cardioprotection. Cardiovasc Res 2009;83:354–361.
   PubMed Web of Science ®Google Scholar
• Yamamoto N, Sawada H, Izumi Y, Kume T, Katsuki H, Shimohama S, Akaike A. Proteasome inhibition induces glutathione synthesis and protects cells from oxidative stress: relevance to Parkinson disease. J Biol Chem 2007;282:4364–4372.
   PubMed Web of Science ®Google Scholar
• Du ZX, Yan Y, Zhang HY, Liu BQ, Gao YY, Niu XF, et al. Proteasome inhibition induces a p38 MAPK pathway-dependent antiapoptotic program via Nrf2 in thyroid cancer cells. J Clin Endocrinol Metab 2011;96:E763–E771.
   Google Scholar
• Halasi M, Wang M, Chavan TS, Gaponenko V, Hay N, Gartel AL. ROS inhibitor N-acetyl-L-cysteine antagonizes the activity of proteasome inhibitors. Biochem J 2013;454:201–208.
   PubMed Web of Science ®Google Scholar
• Estrela JM, Ortega A, Obrador E. Glutathione in cancer biology and therapy. Crit Rev Clin Lab Sci 2006;43:143–181.
   PubMed Web of Science ®Google Scholar
• Forman HJ, Zhang H, Rinna A. Glutathione: overview of its protective roles, measurement, and biosynthesis. Mol Aspects Med 2009;30:1–12.
   PubMed Web of Science ®Google Scholar
• Lu SC. Regulation of glutathione synthesis. Mol Aspects Med 2009;30:42–59.
   PubMed Web of Science ®Google Scholar
• Espinosa-Diez C, Fierro-Fernandez M, Sanchez-Gomez FJ, Rodriguez-Pascual F, Alique M, Ruiz-Ortega M, et al. Targeting of gamma-glutamyl-cysteine ligase by miR-433 reduces glutathione biosynthesis and promotes TGF-beta-dependent fibrogenesis. Antioxid Redox Signal 2014. [Epub ahead of print]. doi:10.1089/ars.2014.6025.
   PubMed Web of Science ®Google Scholar
• Franklin CC, Backos DS, Mohar I, White CC, Forman HJ, Kavanagh TJ. Structure, function, and post-translational regulation of the catalytic and modifier subunits of glutamate cysteine ligase. Mol Aspects Med 2009;30:86–98.
   PubMed Web of Science ®Google Scholar
• Ishimoto T, Nagano O, Yae T, Tamada M, Motohara T, Oshima H, et al. CD44 variant regulates redox status in cancer cells by stabilizing the xCT subunit of system xc(-) and thereby promotes tumor growth. Cancer Cell 2011;19:387–400.
   PubMed Web of Science ®Google Scholar
• Lewerenz J, Hewett SJ, Huang Y, Lambros M, Gout PW, Kalivas PW, et al. The cystine/glutamate antiporter system x(c)(-) in health and disease: from molecular mechanisms to novel therapeutic opportunities. Antioxid Redox Signal 2013;18:522–555.
   PubMed Web of Science ®Google Scholar
• Lo M, Wang YZ, Gout PW. The x(c)- cystine/glutamate antiporter: a potential target for therapy of cancer and other diseases. J Cell Physiol 2008;215:593–602.
   PubMed Web of Science ®Google Scholar
• Ye P, Mimura J, Okada T, Sato H, Liu T, Maruyama A, et al. Nrf2- and ATF4-dependent upregulation of xCT modulates the sensitivity of T24 bladder carcinoma cells to proteasome inhibition. Mol Cell Biol 2014;34:3421–3434.
   PubMed Web of Science ®Google Scholar
• Hanigan MH, Ricketts WA. Extracellular glutathione is a source of cysteine for cells that express gamma-glutamyl transpeptidase. Biochemistry 1993;32:6302–6306.
   PubMed Web of Science ®Google Scholar
• Huseby NE, Asare N, Wetting S, Mikkelsen IM, Mortensen B, Sveinbjornsson B, Wellman M. Nitric oxide exposure of CC531 rat colon carcinoma cells induces gamma-glutamyltransferase which may counteract glutathione depletion and cell death. Free Radic Res 2003;37:99–107.
   PubMed Web of Science ®Google Scholar
• Karp DR, Shimooku K, Lipsky PE. Expression of gamma-glutamyl transpeptidase protects ramos B cells from oxidation-induced cell death. J Biol Chem 2001;276:3798–3804.
   PubMed Web of Science ®Google Scholar
• Zhang H, Forman HJ. Redox regulation of gamma-glutamyl transpeptidase. Am J Respir Cell Mol Biol 2009;41:509–515.
   PubMed Web of Science ®Google Scholar
• Zhang H, Forman HJ. Signaling pathways involved in phase II gene induction by alpha, beta-unsaturated aldehydes. Toxicol Ind Health 2009;25:269–278.
   PubMed Web of Science ®Google Scholar
• Zhang H, Liu H, Dickinson DA, Liu RM, Postlethwait EM, Laperche Y, Forman HJ. Gamma-glutamyl transpeptidase is induced by 4-hydroxynonenal via EpRE/Nrf2 signaling in rat epithelial type II cells. Free Radic Biol Med 2006;40:1281–1292.
   PubMed Web of Science ®Google Scholar
• Limon-Pacheco JH, Hernandez NA, Fanjul-Moles ML, Gonsebatt ME. Glutathione depletion activates mitogen-activated protein kinase (MAPK) pathways that display organ-specific responses and brain protection in mice. Free Radic Biol Med 2007;43:1335–1347.
   PubMed Web of Science ®Google Scholar
• Zhang H, Liu H, Iles KE, Liu RM, Postlethwait EM, Laperche Y, Forman HJ. 4-Hydroxynonenal induces rat gamma-glutamyl transpeptidase through mitogen-activated protein kinase-mediated electrophile response element/nuclear factor erythroid 2-related factor 2 signaling. Am J Respir Cell Mol Biol 2006;34:174–181.
   PubMed Web of Science ®Google Scholar
• Zipper LM, Mulcahy RT. Inhibition of ERK and p38 MAP kinases inhibits binding of Nrf2 and induction of GCS genes. Biochem Biophys Res Commun 2000;278:484–492.
   PubMed Web of Science ®Google Scholar
• Ravuri C, Svineng G, Huseby NE. Differential regulation of gamma-glutamyltransferase and glutamate cysteine ligase expression after mitochondrial uncoupling: gamma-glutamyltransferase is regulated in an Nrf2- and NFkappaB-independent manner. Free Radic Res 2013;47:394–403.
   PubMed Web of Science ®Google Scholar
• Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001;25:402–408.
   PubMed Web of Science ®Google Scholar
• Jain A, Lamark T, Sjottem E, Larsen KB, Awuh JA, Overvatn A, et al. p62/SQSTM1 is a target gene for transcription factor NRF2 and creates a positive feedback loop by inducing antioxidant response element-driven gene transcription. J Biol Chem 2010;285:22576–22591.
   PubMed Web of Science ®Google Scholar
• Andrews NC, Kotkow KJ, Ney PA, Erdjument-Bromage H, Tempst P, Orkin SH. The ubiquitous subunit of erythroid transcription factor NF-E2 is a small basic-leucine zipper protein related to the v-maf oncogene. Proc Natl Acad Sci USA 1993;90:11488–11492.
   PubMed Web of Science ®Google Scholar
• Demasi M, Shringarpure R, Davies KJ. Glutathiolation of the proteasome is enhanced by proteolytic inhibitors. Arch Biochem Biophys 2001;389:254–263.
   PubMed Web of Science ®Google Scholar
• Sekhar KR, Soltaninassab SR, Borrelli MJ, Xu ZQ, Meredith MJ, Domann FE, Freeman ML. Inhibition of the 26S proteasome induces expression of GLCLC, the catalytic subunit for gamma-glutamylcysteine synthetase. Biochem Biophys Res Commun 2000;270:311–317.
   PubMed Web of Science ®Google Scholar
• Lee MH, Hyun DH, Jenner P, Halliwell B. Effect of proteasome inhibition on cellular oxidative damage, antioxidant defences and nitric oxide production. J Neurochem 2001;78:32–41.
   PubMed Web of Science ®Google Scholar
• Perez-Alvarez S, Solesio ME, Manzanares J, Jordan J, Galindo MF. Lactacystin requires reactive oxygen species and Bax redistribution to induce mitochondria-mediated cell death. Br J Pharmacol 2009;158:1121–1130.36.
   PubMed Web of Science ®Google Scholar
• Pandur S, Ravuri C, Moens U, Huseby NE. Combined incubation of colon carcinoma cells with phorbol ester and mitochondrial uncoupling agents results in synergic elevated reactive oxygen species levels and increased gamma-glutamyltransferase expression. Mol Cell Biochem 2014;388:149–156.
   PubMed Web of Science ®Google Scholar
• Venugopal R, Jaiswal AK. Nrf1 and Nrf2 positively and c-Fos and Fra1 negatively regulate the human antioxidant response element-mediated expression of NAD(P)H:quinone oxidoreductase1 gene. Proc Natl Acad Sci USA 1996;93:14960–14965.
   PubMed Web of Science ®Google Scholar
• Kastle M, Woschee E, Grune T. Histone deacetylase 6 (HDAC6) plays a crucial role in p38MAPK-dependent induction of heme oxygenase-1 (HO-1) in response to proteasome inhibition. Free Radic Biol Med 2012;53:2092–2101.
   PubMed Web of Science ®Google Scholar
• Kwak HB, Lee MS, Kim HS, Cho HJ, Kim JW, Lee ZH, Oh J. Proteasome inhibitors induce osteoclast survival by activating the Akt pathway. Biochem Biophys Res Commun 2008;377:1–6.
   PubMed Web of Science ®Google Scholar
• Tang W, Su G, Li J, Liao J, Chen S, Huang C, et al. Enhanced anti-colorectal cancer effects of carfilzomib combined with CPT-11 via downregulation of nuclear factor-kappaB in vitro and in vivo. Int J Oncol 2014;45:995–1010.
   PubMed Web of Science ®Google Scholar
• Wu WT, Chi KH, Ho FM, Tsao WC, Lin WW. Proteasome inhibitors up-regulate haem oxygenase-1 gene expression: requirement of p38 MAPK (mitogen-activated protein kinase) activation but not of NF-kappaB (nuclear factor kappaB) inhibition. Biochem J 2004;379:587–593.
   PubMed Web of Science ®Google Scholar
• Ling YH, Liebes L, Zou Y, Perez-Soler R. Reactive oxygen species generation and mitochondrial dysfunction in the apoptotic response to Bortezomib, a novel proteasome inhibitor, in human H460 non-small cell lung cancer cells. J Biol Chem 2003;278:33714–33723.
   PubMed Web of Science ®Google Scholar
• Paniagua Soriano G, De Bruin G, Overkleeft HS, Florea BI. Toward understanding induction of oxidative stress and apoptosis by proteasome inhibitors. Antioxid Redox Signal 2014;21:2419–2443.
   PubMed Web of Science ®Google Scholar
• Fribley A, Zeng Q, Wang CY. Proteasome inhibitor PS-341 induces apoptosis through induction of endoplasmic reticulum stress-reactive oxygen species in head and neck squamous cell carcinoma cells. Mol Cell Biol 2004;24:9695–9704.
   PubMed Web of Science ®Google Scholar
• Perez-Galan P, Roue G, Villamor N, Montserrat E, Campo E, Colomer D. The proteasome inhibitor bortezomib induces apoptosis in mantle-cell lymphoma through generation of ROS and Noxa activation independent of p53 status. Blood 2006;107:257–264.
   PubMed Web of Science ®Google Scholar
• Borud O, Mortensen B, Mikkelsen IM, Leroy P, Wellman M, Huseby NE. Regulation of gamma-glutamyltransferase in cisplatin-resistant and -sensitive colon carcinoma cells after acute cisplatin and oxidative stress exposures. Int J Cancer 2000;88:464–468.
   PubMed Web of Science ®Google Scholar
• Singh SV, Srivastava SK, Choi S, Lew KL, Antosiewicz J, Xiao D, et al. Sulforaphane-induced cell death in human prostate cancer cells is initiated by reactive oxygen species. J Biol Chem 2005;280:19911–19924.
   PubMed Web of Science ®Google Scholar
• Wu X, Zhu Y, Yan H, Liu B, Li Y, Zhou Q, Xu K. Isothiocyanates induce oxidative stress and suppress the metastasis potential of human non-small cell lung cancer cells. BMC Cancer 2010;10:269.
   PubMed Web of Science ®Google Scholar
• Reuter S, Schnekenburger M, Cristofanon S, Buck I, Teiten MH, Daubeuf S, et al. Tumor necrosis factor alpha induces gamma-glutamyltransferase expression via nuclear factor-kappaB in cooperation with Sp1. Biochem Pharmacol 2009;77:397–411.
   PubMed Web of Science ®Google Scholar
• Hayden MS, Ghosh S. Shared principles in NF-kappaB signaling. Cell 2008;132:344–362.
   PubMed Web of Science ®Google Scholar
• Visvikis A, Pawlak A, Accaoui MJ, Ichino K, Leh H, Guellaen G, Wellman M. Structure of the 5' sequences of the human gamma-glutamyltransferase gene. Eur J Biochem 2001;268:317–325.
   PubMedGoogle Scholar
• Baeza-Raja B, Munoz-Canoves P. p38 MAPK-induced nuclear factor-kappaB activity is required for skeletal muscle differentiation: role of interleukin-6. Mol Biol Cell 2004;15:2013–2026.
   PubMed Web of Science ®Google Scholar
• Chan HM, La Thangue NB. p300/CBP proteins: HATs for transcriptional bridges and scaffolds. J Cell Sci 2001;114:2363–2373.
   PubMed Web of Science ®Google Scholar
• Delghandi MP, Johannessen M, Moens U. The cAMP signalling pathway activates CREB through PKA, p38 and MSK1 in NIH 3T3 cells. Cell Signal 2005;17:1343–1351.
   PubMed Web of Science ®Google Scholar
• Meissner JD, Chang KC, Kubis HP, Nebreda AR, Gros G, Scheibe RJ. The p38alpha/beta mitogen-activated protein kinases mediate recruitment of CREB-binding protein to preserve fast myosin heavy chain IId/x gene activity in myotubes. J Biol Chem 2007;282:7265–7275.
   PubMed Web of Science ®Google Scholar
• Costes S, Vandewalle B, Tourrel-Cuzin C, Broca C, Linck N, Bertrand G, et al. Degradation of cAMP-responsive element-binding protein by the ubiquitin–proteasome pathway contributes to glucotoxicity in beta-cells and human pancreatic islets. Diabetes 2009;58:1105–1115.
   PubMed Web of Science ®Google Scholar
• Jariel-Encontre I, Salvat C, Steff AM, Pariat M, Acquaviva C, Furstoss O, Piechaczyk M. Complex mechanisms for c-fos and c-jun degradation. Mol Biol Rep 1997;24:51–56.
   PubMed Web of Science ®Google Scholar
• Li M, Wang Y, Hung MC, Kannan P. Inefficient proteasomal-degradation pathway stabilizes AP-2alpha and activates HER-2/neu gene in breast cancer. Int J Cancer 2006;118:802–811.
   PubMed Web of Science ®Google Scholar
• Ye X, Liu SF. Lipopolysaccharide causes Sp1 protein degradation by inducing a unique trypsin-like serine protease in rat lungs. Biochim Biophys Acta 2007;1773:243–253.
   PubMed Web of Science ®Google Scholar